Cargando…
Clinical characteristics and prognosis analysis of patients with de novo ASXL1 ‐mutated AML treated with the C‐HUNAN‐AML‐15 protocol: A multicenter study by the South China Pediatric AML Collaborative Group
BACKGROUND: ASXL1 mutation is an independent prognostic factor in adult acute myeloid leukemia (AML), but its effect on the prognosis of pediatric AML is poorly understood. AIMS: This study aimed to investigate the clinical characteristics and prognostic factors of ASXL1‐mutant pediatric AML from a...
Autores principales: | Zeng, Minhui, Chen, Keke, Tian, Xin, Zou, Runying, Feng, Xiaoqin, Li, Chunfu, Li, Jian, Zheng, Mincui, Mai, Huirong, Yang, Lihua, He, Yingyi, Xu, Honggui, Wen, Hong, He, Xiangling |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10315855/ https://www.ncbi.nlm.nih.gov/pubmed/37132266 http://dx.doi.org/10.1002/cam4.6005 |
Ejemplares similares
-
De novo AML exhibits greater microenvironment dysregulation compared to AML with myelodysplasia-related changes
por: Lopes, Matheus Rodrigues, et al.
Publicado: (2017) -
CALCRL Gene is a Suitable Prognostic Factor in AML/ETO(+) AML Patients
por: Wang, Rongrong, et al.
Publicado: (2022) -
AML1/ETO Oncoprotein Is Directed to AML1 Binding Regions and Co-Localizes with AML1 and HEB on Its Targets
por: Gardini, Alessandro, et al.
Publicado: (2008) -
High EVI1 Expression Predicts Adverse Outcomes in Children With De Novo Acute Myeloid Leukemia
por: Zheng, Yongzhi, et al.
Publicado: (2021) -
The role of the proteasome in AML
por: Csizmar, C M, et al.
Publicado: (2016)